Awarded Ono Breast Tender

Contract Award for Contract awarded for : Ono type DX Breast Recurrence Score Test

Oncotype dx is a clinically validated multigene assay for predicting the likely benefit of
chemotherapy in this patient population and is uniquely available from the current supplier on
the global market.
Contract start date: 1 July 2026
tender_issue_date : 26/10/2026.Ono type DX Breast Recurrence Score Test